Isolated ostial stenosis of the left main coronary artery (LMCA) is rare, occurring in <1% of the patients undergoing coronary angiography. Surgical patch angioplasty (SPA) offers an alternative to conventional coronary artery bypass grafting (CABG) in such cases and is advantageous in restoring more physiological myocardial perfusion, maintaining ostial patency and preserving conduit material. However, a number of early technical failures and high perioperative mortality have limited the generalized uptake of this procedure, and only recently have advances in myocardial protection and novel surgical approaches to the LMCA resulted in a resurgence of the technique. A systematic literature search identified 45 studies incorporating 478 patients undergoing SPA. A variety of patch materials were used, including the pericardium, saphenous vein and internal mammary and pulmonary arteries. Patients were followed up for a mean of 54.4 months. The 30-day mortality was 1.7% and cardiac specific mortality 3.3% at last follow-up. Encouragingly, 92.4% of reported cases (n = 182) showed complete angiographic patency at last follow-up. Our results indicate that SPA may be a viable alternative to CABG in the surgical management of isolated ostial LMCA stenosis. However, no randomized trials have been performed, and it is clear that careful patient selection is essential in minimizing morbidity and mortality in the short-and long-term. Further research is required to allow a direct comparison of SPA to techniques with a more substantial evidence base such as CABG and percutaneous coronary intervention, and to define the optimal patch graft material, elucidating that any beneficial effects arterial patches may have on long-term patency.
INTRODUCTION
Isolated ostial stenosis of the left main coronary artery (LMCA), in the absence of other significant coronary disease, affects 0.2-0.88% of all patients undergoing coronary angiography [1] [2] [3] [4] . While the aetiology of this rare disease pattern is commonly atherosclerotic in origin, it may also be associated with systemic conditions such as Takayasu's and syphilitic aortitis, or occur as a consequence of iatrogenic injury following coronary angiography, ostial cardioplegia or mediastinal radiation therapy [1] . Rarely, idiopathic fibromuscular dysplasia has been observed in the pathological analysis of biopsy specimens [5, 6] . The presentation of ostial stenosis frequently differs from other patterns of coronary disease, giving rise to a shorter history of more severe angina. Furthermore, ostial stenosis exhibits a female preponderance [1, 4, 7] and often occurs in the absence of other risk factors for coronary disease.
Surgical patch angioplasty (SPA) was first described by both Effler et al. [8] and Sabiston et al. [9] in 1965 as a technique whereby coronary reconstruction could be achieved using an autologous patch graft, restoring antegrade flow to the myocardium [8, 9] . However, high perioperative mortality and early surgical failure prevented the more generalized uptake of this procedure, ultimately leading to its abandonment in favour of coronary artery bypass grafting (CABG) [8] . With advances in cardioplegic solutions and myocardial protection, SPA was reintroduced by Hitchcock et al. [10] in 1983, demonstrating promising results in patients with isolated LMCA disease. Consequently, renewed interest led to a number of publications reporting several modifications of the technique, utilizing a variety of patch materials and approaches to the left coronary ostium.
This review aimed to address the role of SPA alongside more widely used methods of myocardial revascularization and to summarize the short-and long-term outcomes presented within the literature. Furthermore, we aimed to provide an evidence base on which to identify those patients in whom SPA may prove beneficial.
'surgical angioplasty' and the following MeSH terms: 'Angina Pectoris/Surgery' OR 'Angina, Unstable/Surgery' AND 'Coronary Disease' OR 'Coronary Vessels/Surgery' OR 'Angioplasty/ Methods' OR 'Coronary Artery Bypass'. Articles were also identified using the 'related articles' function in MEDLINE and screening of the reference lists of manuscripts identified in the original search.
All studies reporting SPA for ostial LMCA stenosis were included in the outcome analysis. Articles were excluded where SPA was performed for lesions other than LMCA, in a paediatric population or where publication was not in the English language. In the case of duplicate publication, only the most updated study was included in our analysis. Owing to the small number of cases of isolated SPA, those studies reporting concomitant procedures, including aortic and mitral valve surgery, were not excluded but are discussed in our overall interpretation of results. Data extraction was performed by two independent reviewers (L.H. and A.H.S.) according to a predefined protocol, and short-and long-term outcomes were assessed. Short-term outcomes of interest include: (i) 30-day mortality, (ii) early reintervention rate and (ii) 30-day major cardiac and cerebrovascular events (MACCE). Long-term outcomes include: (i) mortality at last follow-up, (ii) reintervention rate at last follow-up, (iii) angiographic patency at last follow-up and (iv) MACCE at last followup. The last search date was 1 June 2011.
SPA: evolution of the technique
Effler et al. and Sabiston et al. independently reported the first series of SPA procedures in 1965. The left coronary artery (LCA) was initially approached by either median sternotomy [8] or extended anterior thoracotomy (transecting the sternum) [9] , with the latter reported to potentially improve exposure to the proximal LCA/LMCA [8] . After the initiation of cardiopulmonary bypass (CPB) and identification of the LCA, a linear arteriotomy overlying the constricting lesion was performed, followed by the dilatation of the distal vessel and surgical patch reconstruction using either the saphenous vein or the pericardium. However, in these early procedures, exposure of the LCA was often inadequate, complicating graft reconstruction and resulting in an unacceptably high mortality rate. As such, the procedure was somewhat abandoned in favour of conventional CABG until the early 1980s.
In 1983, Hitchcock et al. [10] described the first posterior approach to the LMCA using a spiral aortotomy (Figure 1a) . By incising the aorta from the left to the right between the non-coronary and left coronary cusp and rolling the aortic root to the left, this technique improved the exposure to the LMCA. The posterior wall of the LMCA could then be incised across the stenosis and saphenous vein patch graft reconstruction performed. Dion et al. [11] followed this approach early in their patient series. However, continued difficulty providing adequate access to the LMCA led to the adoption of the now almost exclusively utilized 'anterior' approach [12] . This technique provides a direct visualization of the LMCA from the ostium to the bifurcation by retracting the pulmonary artery (PA) away from the aorta (Figure 1b) . Although similar to the trans-pulmonary approach proposed by Villemot et al. [13] in 1988 (Figure 1c) , it aims to avoid the complete transection of the PA and thus reduces invasiveness. As a consequence of this improved exposure, the arteriotomy may be commenced anteriorly on the ascending aorta and extended leftward to the ostium of the LMCA, thus preventing kinking of the patch graft after the repair, as well as allowing conversion to classical CABG or access to the aortic valve where necessary [11] . The only patch graft is sutured in a continuous fashion, taking care to create a funnel shape, enlarging both the coronary ostium and the aortotomy.
The most recent approach to the left main stem (LMS) is that proposed by Liska et al. [14] in 1999. The aorta is transected, the aortic root mobilized anteriorly and the PA retracted leftwards, allowing the arteriotomy to be commenced just medial to the non-coronary commissure and extended obliquely to the roof of the LMS (Figure 1d ). However, despite good results in their 18 patient series, the technique as described by Dion et al. remains the least invasive and most widely used approach to LMCA SPA.
Techniques in the management of isolated ostial LMCA stenosis: the role of CABG and percutaneous coronary intervention CABG is the most extensively used surgical technique in the revascularization of LMCA stenosis (>50%), particularly in the setting of diffuse coronary disease. It is globally recognized to improve prognosis in such patients and consequently forms the mainstay of treatment in both European and American revascularization guidelines (level of evidence Class 1A) [15] . However, while effective at restoring myocardial blood flow and providing prognostic benefit, revascularization by CABG results in less physiological, retrograde perfusion to an extensive area of the myocardium, occlusion of the left coronary ostium, consumption of conduit material and may accelerate distal atherosclerosis [12] . First performed by Andreas Grüntzig in 1977, percutaneous coronary intervention (PCI) is now the recommended first-line therapy in the treatment of single-or double-vessel disease. Furthermore, recent improvements in stent technology and antiplatelet therapy have broadened the indications for PCI, and results from the SYNTAX trial have fuelled a change in European revascularization guidelines, recognizing PCI as a viable although inferior alternative to CABG in isolated LMCA stenosis (SYNTAX score <22) [15, 16] . However, concerns over unprotected left main stem PCI continue to be raised, particularly regarding stent restenosis and higher long-term rates of repeat revascularization. In their randomized trial of 201 patients, Boudriot et al. [17] failed to demonstrate the non-inferiority of PCI (sirolimus-eluting stent) when compared with CABG at 1 year, and although Park et al. [18] do demonstrate non-inferiority for their composite endpoint of MACCE with PCI at both 1 and 2 years, a significantly higher 2-year ischaemia-driven revascularization rate is seen in the PCI group when compared with CABG.
SPA provides a further alternative in the revascularization of isolated ostial LMCA stenosis, restoring more physiological myocardial perfusion without consuming conduit material. By maintaining an antegrade flow throughout the coronary tree, SPA avoids the retrograde perfusion and subsequent drop in head pressure in a number of coronary branches (the Prizometer principle; Figure 2 ) [10, 19] seen with conventional coronary bypass using a venous or LIMA graft. In addition, by maintaining the ostial patency, SPA allows for PCI of any subsequently developing distal stenoses. The indications for SPA are, however, considerably more limited than either CABG or PCI and a direct, randomized comparison between PCI, CABG and SPA is yet to be performed.
Analysis of outcomes following SPA
A total of 45 studies [6, [10] [11] [12] [13] [14] , incorporating 478 patients, have described variations in the technique of SPA to the LMCA since Effler and Sabiston's first description of the procedure in 1965 (Table 1) . Seven Non-English language papers were also identified but subsequently excluded from the analysis [59] [60] [61] [62] [63] [64] [65] . The most widely used patch materials are the saphenous vein (239 cases) and the pericardium (169 cases), although the internal mammary artery (IMA) and the pulmonary artery (PA) have also been utilized as graft materials (66 and four cases, respectively). A number of elective concomitant procedures were also performed, which include: 100 CABG, 114 coronary endarterectomies, 11 right coronary surgical angioplasties, 15 AVR (+1 valvuloplasty), 10 mitral valve procedures (repair or replacement), three aortic root replacements, one modified Brom aortoplasty, two ASD closures, one excision of left ventricular (LV) aneurysm, two Maze III procedures and one sympathetic plexus denervation.
Short-term outcomes
A summary of the early postoperative results is shown in Table 2 . As previously described, the high early mortality reported in Effler's series (reaching 45%) was one of the key reasons for the poor uptake of SPA in the first 20 years after its conception; the overall 30-day mortality of this pooled series of data is, however, significantly lower at 1.7% (8 of 478 patients). Botman et al. [22] report the highest early mortality in their series of 31 patients (three deaths). Notably, the second death occurred as a direct consequence of the failure of the patch reconstruction, resulting in acute closure of the LMCA and extensive myocardial infarction 2 days after surgery. Of the two deaths reported by Dion et al. in Figure 2 : The Prizometer principle. Originally described by Hitchcock et al. [10] , this model demonstrates the Prizometer principle whereby vessel (a) is perfused retrogradely, experiencing a reduced head pressure compared with vessel (c), which is perfused antegradely. their 47 patient series, the first occurred as a consequence of heavy calcification of the LMCA not permitting SPA. Conventional CABG was attempted, but despite successful grafting of the left anterior descending artery (LAD), the inability to identify the circumflex artery led to ongoing myocardial ischaemia, inability to wean from bypass and intraoperative death [12] . In their 10 patient series, Schmuziger and Christenson [49] also reported one case (third time re-do revascularization) of heavy calcification of the LMCA, resulting in an inability to perform SPA and distal embolization to the circumflex artery, myocardial infarction and intraoperative death. Other causes of death included mediastinitis/sepsis, right coronary artery air embolism, mesenteric infarction and acute myocardial infarction (MI) secondary to vasospasm ( patent LMCA graft). These are outlined in Table 3 . The overall surgical reintervention rate was 3.9% (7/178 cases), as reported by six studies incorporating 178 patients. Postoperative non-fatal MI occurred in 1.2% of the patients (20 studies, 438 patients), renal failure occurred in 3.4% (7/205, six studies) and arrhythmia in 21.5% (28/130, five studies). No episodes of perioperative stroke were observed in the five studies directly reporting this outcome.
Long-term outcomes
Patients were followed up for a mean of 54.4 months following SPA. Mortality at last follow-up was 8.0% (37 studies, 36/449 patients), with 14 cases (3.1%) attributed to cardiac causes. The causes of late mortality are shown in Figure 3 . Notably, 46% (6/13) of the cardiac-related deaths were attributed to the progression of coronary artery disease, with a further two deaths occurring as a result of complications of repeat revascularization. None of these deaths were reported to have occurred as a consequence of restenosis at the point of patch graft reconstruction.
Assessment of patch graft patency was made by a number of methods including angiography, cardiac magnetic resonance imaging, transoesophageal echo (TOE), intravenous ultrasound (IVUS), thallium scintiscan assessment of myocardial perfusion defects and myocardial stress testing. Short-term angiographic patency was reported by seven studies at a rate of 97.7%; at last follow-up (19 studies, 183 patients), the angiographic patency was 92.3% (169/183). The patency rate as confirmed by other modalities is stated in Table 2 .
Subgroup analysis
Patch graft material. Four varieties of the patch graft material were utilized, including 169 autologous pericardia, 239 saphenous veins, 66 internal thoracic arteries and four pulmonary artery grafts. Table 4 shows the incidence of restenosis according to the patch type.
LMCA calcification. Eight studies describe 41 cases of SPA in the setting of angiographically evident LMCA calcification [12, 14, 25, 32, 36, 38, 47, 49] . An additional 23 patients had significant LMCA calcification not visible on coronary angiography but identified intraoperatively. Overall, six patients required intraoperative conversion to conventional CABG (9.3%) and a further three patients presented with late restenosis [20] 3h -haemodyanmic compromise from arterial vasospasm. PM: SPA patent Schmuziger and
Christenson [49] Intraoperative-third time coronary revascularization, unsuspected dissected calcified plaque of the ostium, distal embolization occurred leading to Cx thrombosis and MI Maureira et al. [38] Mesenteric infarction and multiorgan failure (timing not specified)
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requiring CABG (4.6%). Notably, one patient requiring repeat revascularization presented with acute MI 6 months after SPA [36] . The overall mortality in patients with LMCA calcification was 3.1% (2/64).
LV function. Of the 14 studies reporting preoperative LV function, a total of nine studies [12, 14, 21, 32, 36, 38, 44, 46, 50] (64 patients) performed SPA on patients with LV dysfunction (<50%). One death was reported following SPA in a patient with preoperative LV failure [12] ; however, no other complications were reported in this group. Furthermore, two patients showed moderate improvement (from 15 to 35% and 25 to 40%) and five normalized their LV function [12, 50] . Overall, LV impairment was not considered a contraindication to SPA.
Concomitant thromboendarterectomy. Seven studies [12, 13, 21, 36, 38, 49, 56] performed concomitant thromboendarterectomy and SPA in a total of 111 patients. Intraoperatively, one patient required concomitant CABG and one patient converted to conventional CABG. Within this group, 10 patients (9.0%) presented with restenosis requiring intervention. Seven of these patients underwent PCI between 6 months and 3.9 years following SPA. CABG was performed in the remaining three patients between 3 and 13.2 months following SPA. No other specific complications were reported.
Involvement of mid/distal LMS and bifurcation stenoses.
Eight studies reported SPA in patients with mid-to distal LMS stenoses [12, 31, 32, 35, 36, 38, 39, 47] . Of these, 71 cases involved the middle 1/3, 20 involved the mid-to distal 1/3, five involved the distal 1/3, five involved the whole length and 10 involved the bifurcation of the LMS. While Dion et al. [12] report no additional technical failures in their last 26 patients despite 15 cases (57.7%) of mid-and/or distal LMCA stenoses, a number of complications have been observed in this group. Early complications include, one failure to wean from bypass and intraoperative conversion to CABG [35] , one elective intraoperative conversion to CABG [36] and one reoperation (CABG) prior to discharge due to unrecognized distal LMCA stenosis on postoperative angiography [32] . Late LMCA restenosis requiring reintervention occurred in four patients at a mean of 1.1-year post-procedure [31, 38] .
DISCUSSION

Indications
SPA of the LMCA was initially used cautiously. Earlier in their work, Dion et al. [11] describe applications of the technique only in cases of proximal, non-calcified LMCA stenosis in patients below 60 years of age. Encouraged by preliminary results, these indications were expanded to include older patients and those with more distal stenoses, visible angiographic calcifications or impaired LV function [12] . While both age and poor LV function have not been found to contraindicate SPA (in fact, both Dion et al. [12] and Sharoni et al. [50] report cases of improvement in LV function following SPA revascularization), the results from SPA in the setting of angiographically evident LMCA calcification have been disappointing. The higher 30-day mortality (3.1 vs 1.4%) and conversion to conventional CABG (9.3%) seen in our pooled data set reflect a number of early technical failures in patients with heavy calcification of the LMCA [11, 12] . Moreover, despite early technical success, a further 4.8% of the patients presented with late restenosis requiring CABG. Extensive angiographic evidence of calcification therefore almost universally remains an absolute contraindication to SPA, a conclusion supported by our findings [12, 21, 22, 25, 36, 38, 49] . The extent of LMCA stenosis is a further important consideration in selecting patients for SPA. A number of cases have been performed on lesions extending beyond the ostium, into the mid-to distal LMCA and even past the bifurcation. However, despite good results in experienced institutions, SPA in such cases is more technically demanding, and emergency conversion to CABG in such cases is not infrequent. Consequently, nonostial stenosis remains an absolute contraindication to SPA in the majority of centres. Both Jegaden et al. [31] and Maureira et al. [38] report restenosis requiring reintervention in such patients at a mean of only 1.1 years following SPA. Furthermore, both cases of early restenosis reported by Meseguer et al. [39] occurred in patients with non-ostial lesions, suggesting that even lesions of the proximal LMCA may be at increased risk of late complications. As such, we believe that the present recommendations correctly contraindicate SPA in cases of stenosis extending beyond the proximal LMCA, and conventional CABG should remain the gold standard for such patients. Where SPA is performed on more distal LMS pathology involving the proximal LAD, it is paramount to ensure the absence of visible calcification or associated circumflex pathology.
Despite conventional preoperative angiographic assessment, a failure to fully appreciate the degree of calcification and the extent of stenosis is well documented. We therefore agree with Maureira et al. [38] that preoperative multidetector spiral computed tomography (CT) and/or intravascular ultrasound should be considered in order to more accurately quantify the LMS plaque burden, improve patient selection and ultimately benefit patient outcomes [66] .
Selection of the optimal patch graft material
The saphenous vein and autologous pericardium have historically been the most commonly utilized patch materials; however, with the increasing use of IMA and to a lesser extent PA grafts, there is currently no consensus over the optimal patch type. The saphenous vein is favoured by a number of surgeons as its size and character allow simple creation of a funnel-shaped ostium [23, 36] . However, its elasticity may bring about a tendency to dilatation [36, 46] , and smooth muscle cell migration and proliferation may result in accelerated intimal hyperplasia leading to long-term restenosis [14, 46] . IMA patch grafts more closely mimic the characteristics of the native coronary artery, but may be limited by the requirement for conduit harvest, thus negating a potential benefit of SPA. The pericardium is easily harvested, readily available and allows for the preservation of future conduit material. However, its lack of fibrinolytic properties may theoretically promote calcification and subsequent restenosis. Although we observe only a small number of both early and late restenoses following SPA [0.4% (2/478) and 1.5% (7/478), respectively], the pericardium appears to be associated with a slightly higher rate of late restenosis when compared with other patch materials (2.4 vs 1.3% saphenous vein vs IMA and PA 0%). While this raises a question over the long-term longevity of the pericardial patch, there is currently insufficient evidence to quantify the significance of this effect, and inter-study variations in the surgical technique, disease pattern and aetiology limit further interpretation.
The beneficial effects of arterial conduits on long-term patency in conventional CABG have been acknowledged for a number of years [67] . Not only are saphenous vein grafts susceptible to traumatic damage during harvesting and implantation; but the higher, cyclical, transmural pressure of the epicardial environment may stimulate smooth muscle proliferation and accelerate atherosclerosis [68] . In contrast, the IMA exhibits a much closer histological comparability to the native coronary artery and displays several biological and physiological characteristics that act to reduce tissue proliferation, neointimal hyperplasia and atherosclerosis [67] . Presently, no early or late restenosis has been reported in patients undergoing SPA with either IMA or PA patches; however, the number of procedures remains small (66 and four patches, respectively) and further long-term follow-up is required.
Anticoagulation
Antiplatelet agents both reduce the risk of early occlusion and promote long-term vein graft patency following conventional CABG [69] . Consequently, existing guidelines recommend that aspirin was given within 12 h postoperatively to all patients without contraindications, at a dose of 150-325 mg [70] . However, no consensus of opinion currently exists on the optimal anticoagulation strategy following SPA. In the largest series to date (n = 91), Maureira et al. report a repeat myocardial revascularization rate of 12 ± 6.8% at 5 years (three ostial restenosis, seven progression of atherosclerosis requiring reintervention), despite early anticoagulation with both aspirin and 3 months warfarinization [38] . In their smaller series, both Liska et al. [14] (n = 18) and Raanani et al. [47] (n = 15) advocate warfarinization for 2 and 6 months, respectively (international normalized ratio 2-3), and report no cases of either acute graft occlusion or late restenosis. Comparable results have, however, been reported with less aggressive strategies utilizing low-dose aspirin alone, suggesting that warfarinization may be unnecessary in some cases [22] [23] [24] .
This varying approach undoubtedly reflects the influence of several pre-and intraoperative factors on attaining a balance between the risks and benefits of anticoagulation. Furthermore, recent advances in dual antiplatelet therapy (aspirin and clopidogrel) in the setting of both conventional CABG and non-surgical angioplasty may also offer a therapeutic benefit [70] . However, currently no studies address the role of dual antiplatelet therapy following SPA, and consequently, any potential benefits must be weighed against the recognized side effects of such a regimen.
While there is currently insufficient evidence to advocate any particular protocol, disease aetiology, prior/adjunctive procedures, extent of stenosis and patch graft material must all be taken into consideration, not only to minimize postoperative bleeding and blood product requirement but also early thrombus formation, graft restenosis and late disease progression.
LIMITATIONS
Several limitations in both study design and outcome reporting influence the interpretation of these results. First, all studies SURGICAL TECHNIQUE included in this review are observational, and it is largely unclear whether data were prospectively or retrospectively collected. No randomized controlled trials have been performed, and there is no available comparison between SPA and existing alternatives such as PCI or conventional CABG. Secondly, the majority of reports are of individual cases or small case series with only two larger (n > 40) studies available from experienced centres. Furthermore, inter-study variations in disease aetiology, extent of LMCA stenosis, concomitant procedures, patch graft material and postoperative anticoagulation strategies are likely to influence pooled results and should be taken into consideration when interpreting such outcome data.
CONCLUSIONS
Despite early concerns over high perioperative mortality and difficulties in surgical exposure, SPA has evolved to be a viable alternative to CABG in the surgical management of isolated ostial LMCA stenosis. By maintaining ostial patency and restoring more physiological perfusion without consuming conduit material, this technique also holds future advantages in this typically young patient cohort. However, this technically demanding procedure is currently only utilized by a select number of skilled surgeons and certain limitations must be carefully taken into consideration in selecting the appropriate surgical candidate. While age and poor ventricular function do not preclude patients from SPA, angiographically evident calcification and stenosis extending beyond the ostium may not only lead to intraoperative difficulties but also negatively influence both short-and long-term morbidity and mortality. Consequently, preoperative CT angiography and/or intravascular ultrasound should be considered, defining both the extent of stenosis and the degree of calcification prior to SPA. The selection of the optimal patch graft material also remains the subject of debate. While excellent results have been attained with arterial patches, the number of such procedures remains small. An autologous pericardium is readily available; however, some concerns are raised over its long-term patency, identifying a potentially higher incidence of late ostial occlusion. As such, we advocate the restriction of pericardial patches strictly to ostial stenosis, in order to reduce patch size, preserve laminar flow and improve longevity. Further research is required, not only to allow a direct comparison of SPA with both CABG and PCI, but also to define the optimal patch graft material and elucidate any beneficial effects that arterial patches may have on long-term patency. 
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